Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Perphenazine Tablets Recalled by Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals Due to Tablet Separation: Possibility of cracked or split coating...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals directly.
Affected Products
Perphenazine Tablets, USP, 8 mg, 100-count tablets per bottle, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-5092-21.
Quantity: 2,755 bottles
Why Was This Recalled?
Tablet Separation: Possibility of cracked or split coating on the tablets.
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals
Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals has 5 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report